Abstract
Information regarding the magnitude of hepatitis C virus (HCV) infection among thalassemia patients is of great importance for health care providers to assess blood safety and improve the quality of screening systems. Therefore, this study evaluated the prevalence, risk factors, and genotypic pattern of HCV infection among β-thalassemia patients in South Iran.
Keywords
Publication details
- DOI
- 10.5001/omj.2022.85
- Journal
- Oman Medical Journal
- Publisher
- Oman Medical Specialty Board
- Open access
- Gold open access
Cite this article
APA 7
Farshadpour, F., & Taherkhani, R. (2022). Prevalence and Molecular Evaluation of Hepatitis C Virus Infection among Multi-transfused Thalassemia Patients in South of Iran. Oman Medical Journal. https://doi.org/10.5001/omj.2022.85
MLA 9
Farshadpour, Fatemeh, and Reza Taherkhani. "Prevalence and Molecular Evaluation of Hepatitis C Virus Infection among Multi-transfused Thalassemia Patients in South of Iran." Oman Medical Journal, 2022. https://doi.org/10.5001/omj.2022.85.
Chicago (author–date)
Farshadpour, Fatemeh, and Reza Taherkhani. 2022. "Prevalence and Molecular Evaluation of Hepatitis C Virus Infection among Multi-transfused Thalassemia Patients in South of Iran." Oman Medical Journal. https://doi.org/10.5001/omj.2022.85.
Harvard
Farshadpour, F. and Taherkhani, R. (2022) 'Prevalence and Molecular Evaluation of Hepatitis C Virus Infection among Multi-transfused Thalassemia Patients in South of Iran', Oman Medical Journal. doi:10.5001/omj.2022.85.
Vancouver
Farshadpour F, Taherkhani R. Prevalence and Molecular Evaluation of Hepatitis C Virus Infection among Multi-transfused Thalassemia Patients in South of Iran. Oman Medical Journal. 2022. doi:10.5001/omj.2022.85
IEEE
F. Farshadpour, and R. Taherkhani, "Prevalence and Molecular Evaluation of Hepatitis C Virus Infection among Multi-transfused Thalassemia Patients in South of Iran," Oman Medical Journal, 2022, doi: 10.5001/omj.2022.85.